![Mann Muhsin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Mann Muhsin worked as a Medical Director-Oncology Clinical Development at Halozyme Therapeutics, Inc. from 2016 to 2019.
He then worked as a Senior VP-Oncology Clinical Development at HUYA Bioscience International LLC from 2019 to 2020.
In 2021, he became the Chief Medical Officer at Medicenna Therapeutics Corp.
Dr. Muhsin earned a doctorate degree from the University of Baghdad.
Former positions of Mann Muhsin
| Companies | Position | End |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Chief Tech/Sci/R&D Officer | 2022-01-16 |
Huyabio International LLC
 Huyabio International LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Corporate Officer/Principal | 2020-03-31 |
| HALOZYME THERAPEUTICS, INC. | Corporate Officer/Principal | 2019-02-28 |
Training of Mann Muhsin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
18
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Huyabio International LLC
Huyabio International LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
University of Baghdad
 University of Baghdad Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medicenna Therapeutics Corp.
 Medicenna Therapeutics Corp. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Mann Muhsin
